PTC Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) announced executive presentations at three investor conferences in May–June 2026. Scheduled appearances: Bank of America Health Care Conference on May 12, RBC Capital Markets Global Healthcare on May 20, and Goldman Sachs Global Healthcare Conference on June 9.
Each presentation will be webcast live and archived for 30 days on PTC Therapeutics' investor Events and Presentations page.
Positive
- None.
Negative
- None.
News Market Reaction – PTCT
In the May 4 session, PTCT gained 0.52%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Bank of America Securities Health Care Conference 2026
Tuesday, May 12 at 8:40 a.m. PDT / 11:40 a.m. EDT
RBC Capital Markets 2026 Global Healthcare Conference
Wednesday, May 20 at 10 a.m. EDT
Goldman Sachs 47th Annual Global Healthcare Conference
Tuesday, June 9 at 9:20 a.m. EDT
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302760778.html
SOURCE PTC Therapeutics, Inc.